Search results
STEALTH BIOTHERAPEUTICS' BARTH SYNDROME NDA RECEIVES PRIORITY REVIEW DESIGNATION
FOX 59 Indianapolis· 2 hours agoStealth BioTherapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction ...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 1 day agodropped nearly 30% in premarket trading Monday after the company said its experimental...
Roche’s VABYSMO has successful Q1 sales despite Regeneron and Bayer’s EYLEA HD launch
Pharmaceutical Technology via Yahoo Finance· 6 days agoLast week, Roche released promising first-quarter (Q1) 2024 sales figures for VABYSMO, a vascular...
Why Is EyePoint Pharmaceuticals Stock Plummeting On Monday?
Benzinga via Yahoo Finance· 1 day agoOn Monday, EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) announced the topline results of its Phase 2...
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 5 days agoThree at-home vision-monitoring tools failed to detect worsening neovascular age-related macular ...
Three-dimensional retinal electrodes in a convex Braille shape partially restore sight
Medical Xpress· 2 hours agoA research team led by Professor Sohee Kim of the Department of Robotics and Mechatronics...
Can You Take Vitamin C and Iron Together?
Health via Yahoo News· 7 days agoIron is often sold in products that also contain vitamin C. Vitamin C can enhance iron absorption, but, as with all supplements, there are...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 15 hours ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
...Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry...
Benzinga· 6 days agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 4 days agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that could herald a sea ...